TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models

Authors: Hackett, Christopher S., Hirschhorn, Daniel, Tang, Meixian S., Purdon, Terence J., Marouf, Yacine, Piersigilli, Alessandra, Agaram, Narasimhan P., Liu, Cailian, Schad, Sara E., de Stanchina, Elisa, Rafiq, Sarwish, Monette, Sebastien, Wolchok, Jedd D., Merghoub, Taha, Brentjens, Renier J.

Source: In Molecular Therapy: Oncology 19 September 2024 32(3)

Multipurposing CARs: Same engine, different vehicles

Authors: Hossian, A.K.M. Nawshad, Hackett, Christopher S., Brentjens, Renier J., Rafiq, Sarwish

Source: In Molecular Therapy 6 April 2022 30(4):1381-1395

Expression Quantitative Trait Loci and Receptor Pharmacology Implicate Arg1 and the GABA-A Receptor as Therapeutic Targets in Neuroblastoma

Authors: Hackett, Christopher S., Quigley, David A., Wong, Robyn A., Chen, Justin, Cheng, Christine, Song, Young K., Wei, Jun S., Pawlikowska, Ludmila, Bao, Yun, Goldenberg, David D., Nguyen, Kim, Gustafson, W. Clay, Rallapalli, Sundari K., Cho, Yoon-Jae, Cook, James M., Kozlov, Serguei, Mao, Jian-Hua, Van Dyke, Terry, Kwok, Pui-Yan, Khan, Javed, Balmain, Allan, Fan, QiWen, Weiss, William A.

Source: In Cell Reports 6 November 2014 9(3):1034-1046

Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC

Authors: Swartling, Fredrik J., Savov, Vasil, Persson, Anders I., Chen, Justin, Hackett, Christopher S., Northcott, Paul A., Grimmer, Matthew R., Lau, Jasmine, Chesler, Louis, Perry, Arie, Phillips, Joanna J., Taylor, Michael D., Weiss, William A.

Source: In Cancer Cell 15 May 2012 21(5):601-613

Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma

Authors: Cheng, Andy J., Ching Cheng, Ngan, Ford, Jette, Smith, Janice, Murray, Jayne E., Flemming, Claudia, Lastowska, Maria, Jackson, Michael S., Hackett, Christopher S., Weiss, William A., Marshall, Glenn M., Kees, Ursula R., Norris, Murray D., Haber, Michelle

Source: In European Journal of Cancer 2007 43(9):1467-1475

Pleiotropic role for MYCN in medulloblastoma.

Authors: Swartling, Fredrik J., Grimmer, Matthew R., Hackett, Christopher S.

Source: Genes & Development; May 15 2010, Vol. 24 Issue 10, p1059-1072, 14p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

520. ProTIS, a Method for Prediction of Insertion-Site Preferences into Chromosomes of Vectors Used for Gene Therapy

Authors: Geurts, Aron M., Hackett, Christopher S., Bell, Jason B., Bergemann, Tracy L., Collier, Lara S., Carlson, Corey M., Largaespada, David A., Hackett, Perry B.

Source: In Molecular Therapy 2006 13 Supplement 1:S200-S200

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

176. Target-Site Preferences of Sleeping Beauty Transposons in an Intron of the B-raf Oncogene

Authors: Bell, Jason B.¹, Hackett, Christopher S.², Geurts, Aron M.¹, Carlson, Corey M.¹, Collier, Lara S.¹, Liu, Geyi¹, Largaespada, David A.¹, Hackett, Perry B.^1,3

Source: Molecular Therapy. Jun2005, Vol. 11, p69-70. 2p.

Subject Terms: *TRANSPOSONS, *ONCOGENES